What is the maximum intravenous nitroglycerin infusion rate in drops per minute for a standard micro‑drip set (60 drops = 1 mL) and a macro‑drip set (15 drops = 1 mL)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 23, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Maximum Nitroglycerin Infusion Rate

The maximum intravenous nitroglycerin infusion rate is 200 mcg/min according to ACC/AHA guidelines, which translates to 12,000 drops/hour (200 drops/min) for a micro-drip set or 3,000 drops/hour (50 drops/min) for a macro-drip set. 1

Standard Maximum Dosing

  • The ACC/AHA guidelines establish 200 mcg/min as the standard maximum dose for IV nitroglycerin infusion. 1
  • While higher doses up to 400 mcg/min have been used in specific clinical situations with careful monitoring, 200 mcg/min represents the commonly accepted ceiling when maximal doses are not explicitly defined. 1
  • For hypertensive emergencies specifically, the ACC/AHA recommends a maximum of 20 mcg/min, which is considerably lower than the general maximum. 1

Drip Rate Calculations

Micro-Drip Set (60 drops = 1 mL):

  • At 200 mcg/min maximum: 200 drops/min or 12,000 drops/hour 1
  • This assumes standard nitroglycerin concentration of 200 mcg/mL (50 mg in 250 mL)

Macro-Drip Set (15 drops = 1 mL):

  • At 200 mcg/min maximum: 50 drops/min or 3,000 drops/hour 1
  • Same concentration assumption applies

Titration Guidelines

  • Start at 5-20 mcg/min and increase by 5-10 mcg/min every 3-5 minutes based on clinical response. 1, 2
  • The European Society of Cardiology recommends starting at 10-20 mcg/min with increments of 5-10 mcg/min every 3-5 minutes. 1
  • For hypertensive emergencies, initiate at 5 mcg/min and increase in 5 mcg/min increments every 3-5 minutes to a maximum of 20 mcg/min. 1

Critical Safety Parameters

  • Avoid use if systolic blood pressure is <90 mmHg or has dropped >30 mmHg below baseline. 1, 2
  • In hypertensive patients, do not reduce systolic blood pressure by more than 25% within the first hour. 2
  • Continuous blood pressure monitoring is essential; arterial line placement is recommended for higher doses or borderline blood pressures. 1, 2

Important Clinical Considerations

  • Tachyphylaxis typically develops after 24-48 hours of continuous infusion, necessitating dose escalation. 1, 2
  • Even prolonged infusions at 300-400 mcg/min for 2-4 weeks do not increase methemoglobin levels, though this exceeds standard maximum recommendations. 1
  • Use non-absorbing (polyethylene) tubing rather than standard PVC tubing, as PVC can absorb significant amounts of nitroglycerin and reduce delivered dose. 3, 4

Absolute Contraindications

  • Phosphodiesterase inhibitor use within 24 hours (sildenafil) or 48 hours (tadalafil) due to risk of life-threatening hypotension and death. 1, 5
  • Advanced aortic stenosis, as patients may experience marked hypotension. 1, 2
  • Right ventricular infarction due to preload dependency. 2
  • Volume depletion states. 1

Common Pitfalls

  • Excessive hypotension can occur with rapid titration, especially in volume-depleted patients. 1
  • Headache is a frequent side effect that may require symptomatic management but does not necessitate discontinuation. 1
  • Abrupt cessation can cause rebound ischemia; taper the dose gradually when discontinuing. 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Nitroglycerin Dosing in Critical Care Settings

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Intravenous nitroglycerine in refractory unstable angina pectoris.

Australian and New Zealand journal of medicine, 1982

Guideline

Nitroglycerin Spray Dosing for Angina

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Related Questions

How do I calculate the infusion pump rate for an intravenous nitroglycerin infusion, including starting dose, titration increments, maximum dose, and adjustments for different solution concentrations?
How to make a nitroglycerin (NTG) infusion?
What is the recommended dosing for intravenous (IV) nitroglycerin?
What is the recommended dose of intravenous (IV) nitroglycerin in acute coronary syndrome?
What is the recommended dosing and titration protocol for an intravenous nitroglycerin infusion in an adult patient with acute chest pain?
What is the recommended dosing and titration protocol for an intravenous nitroglycerin infusion in an adult patient with acute chest pain?
Which moderate‑intensity statin is appropriate for a 61‑year‑old male with pre‑diabetes (A1C 5.7 %), triglycerides 182 mg/dL, HDL cholesterol 38 mg/dL, and LDL cholesterol 130 mg/dL?
What is the recommended schedule for monitoring liver function tests (and other labs) in a patient taking oral terbinafine, including baseline testing and follow‑up intervals, and how should this be adjusted for risk factors such as pre‑existing liver disease, heavy alcohol use, or concurrent hepatotoxic medications?
What is the recommended management of a Bartholin cyst in a reproductive‑age woman, including treatment for small asymptomatic cysts, larger or symptomatic cysts, and infected Bartholin abscesses?
In a 33-year-old woman being evaluated for diffuse alveolar hemorrhage, what is the significance of moderate eosinophilia and what are the likely causes and recommended management?
When should the patient with elevated liver enzymes, who is on atorvastatin 10 mg nightly, dulaglutide (Trulicity) 1.5 mg weekly, metformin 500 mg twice daily, ergocalciferol 2000 IU daily, and has discontinued ibuprofen have her liver enzymes rechecked?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.